Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Quintiles, a biopharmaceutical services company, has agreed to acquire Advion BioServices, a US-based bioanalytical laboratory,providing Good Laboratory Practice (GLP)pharmacokinetic/pharmacodynamic (PK/PD) testing and other services.
Subscribe to our email newsletter
The deal is expected to close this quarter, as Advion BioServices will join Quintiles as Advion Bioanalytical Labs, a Quintiles company.
Quintiles Global Laboratories senior vice president Thomas Wollman said the addition of bioanalytical offering to their existing CAP-accredited central labs network would create a one-source solution for lab testing.
"We now can offer customers world-class PK/PD testing, molecular screening, drug discovery and metabolism, biomarker discovery, and immunoassay services to inform decision-making early on, helping reduce the risk of failure in expensive later-stage trials," Wollman added.